In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

1. Excision of the liver (adopted from P.O. Seglen¹² and R. Blomhoff¹³ with modifications ^14,15)

1. Add 10 mL 30% isoflurane in polyethylene glycol to a petri dish in a closed 5.5 L chamber. It is optimal to wait 10-15 min after addition of isoflurane to create a stabilized atmosphere within the chamber.
2. Place a rat in the sealed chamber and allow it to become anesthetized. Full effects of the anesthesia are apparent when the animal becomes limp, unresponsive, and exhibits deep breathing.
3. Place 2 mL of isoflurane in polyethylene glycol in some cotton balls at the bottom of a 30 mL syringe tube.
4. Place the rat on its back on a diaper-covered tray and place the syringe tube over the snout.
5. Immediately confirm deep anesthesia by wetting the abdomen with 70% ethanol. Do not let the animal die by isoflurane overdose.
6. Using bandage scissors and forceps, expose the entire abdominal cavity.
7. Locate the vena porta and, using forceps, draw two strands of surgical silk or polyester thread (ligature) beneath the vena porta immediately above the mesenteric branch.
8. Withdraw the forceps and tie a loose overhand knot.
9. Using forceps underneath the vena porta and gently pulling back to straighten out the vein, cannulate the vein with an Insyte Autoguard catheter (18 GA, 1.3 x 300 mm, BD Biosciences) or similar catheter. The catheter should go several mm beyond the loop formed by the thread.
10. Retract and remove the needle by releasing the spring-loaded trigger on the catheter. Blood should start seeping up into the catheter indicating proper ligature placement.
11. Tighten down the overhand knot and secure it with another overhand knot.
12. Sever either the inferior vena cava or descending aorta (aorta abdominalis) to allow blood to drain from the circulatory system.
13. Begin flushing the liver with oxygenated TBS at 37°C to remove the blood (blanching) at a flow rate of 20 mL/min. The liver should turn from a reddish purple to a loam color.
14. While the liver is flushing, excise the liver by cutting away the GI tract and connective tissue. It is important not to lacerate the liver or puncture the Glisson’s capsule.
15. Place the liver on a plastic net over a funnel that allows buffers to be collected and recirculated. Buffers at this point should not be recirculated, but flow into the waste beaker. Flushing should not last more than 10 min. (Fig. 2A). Prepare the endocytosis solution required in step 2.1.

2. Internalization of ¹²⁵I-SA-b-Hep (or other suitable labeled ligand)

1. To 50 mL RPMI media in a small beaker, add to a final concentration 0.05% BSA and 0.01 mCi ¹²⁵I-SA-b-Hep or other appropriately labeled ligand for endocytosis.
2. Attach this beaker to the apparatus to allow for oxygenation.
3. Turn off the pump, switch the inlet tubing, and then turn on the pump at 20 mL/min.
4. As the labeled RPMI approaches the liver, turn off the pump and allow excess fluid in the funnel and tubing drain.
5. Place the drain tubing into the media beaker to allow recirculation of labeled media and then restart the pump.
6. Allow fluids to recirculate through the liver for no more than 1 hour.
7. During this internalization step, be sure the temperature in the liver is stable by covering it and prepare the collagenase for digestion.

3. Digestion of the liver by collagenase digestion

1. Freshly dissolved and filtered (0.45 μm) collagenase (100 mg/kg rat weight) should be added to Buffer 2 in a total volume not to exceed 60 mL at 37°C. The volume is dependent on the length/internal volume of the tubing and should be adjusted accordingly.
2. Stop the pump and exchange the inlet tubing from the media beaker to the TBS.
3. Flush the liver for 2 min at 50 mL/min which allows for loosening of the desmosomal cell junctions which are calcium dependent.
4. While the liver is flushing, exchange the media beaker with the beaker containing collagenase on the apparatus.
5. Immediately after flushing, begin the digestion with collagenase in a circulatory loop at a flow rate of 20 mL/min for up to 15 min. Since collagenase batches vary by lot number, variations in the amount and time of digestion need to be optimized for every new lot of collagenase. Collagenase is also calcium dependent. Turn off the pump and switch the buffer and gas lines from Flask A to Flask B. Transfer the effluent line from the waste container to Flask B (Fig. 2B).
6. Stop the pump, remove the catheter and transfer the liver to a dish containing 20-30 mL Buffer 1.
7. Peel back the Glisson’s capsule of the liver and shake the cells out in the liquid.
8. As the liquid becomes opaque with cellular material, transfer the cells through a 100 μm mesh followed by filtration through a 30 μm mesh and then into a 50 mL conical on ice.
9. Add more Buffer 1 to the liver and continue shaking cells from the liver matrix, transferring the liquid to the mesh filters and conical.
10. Repeat steps 3.7 to 3.9 until no more cells can be dislodged with reasonable shaking of the liver.

4. Hepatocyte and SEC purification

1. Centrifuge the 50 mL conicals containing cells at 150 x g for 3 min. to pellet the hepatocytes.
2. Transfer the liquid fraction containing non-parenchymal cells to fresh 50 mL conicals on ice.
3. Wash the hepatocytes be resuspending the pellet in Buffer 3 and repeating steps 4.1 and 4.2 three more times.
4. At the end of the washes, the pellets are ≥97% pure hepatocytes. To obtain the SECs, centrifuge all of the tubes containing pooled supernatant (containing HSCs, SECs, and KCs and some small hepatocytes) at 200 x g for 10 min. at 4°C.
5. Aspirate the buffer and resuspend all the pellets in 5 mL RPMI/BSA at 4°C.
6. Pool the cells together into 2 tubes and add RPMI/BSA up to a volume of 35 mL.
7. Centrifuge the conicals at 100 x g for 3 min.
8. Collect the top 25 mL of liquid and transfer to a clean 50 mL conical.
9. Resuspend the pellet in the remaining 10 mL media and add back 25 mL of cold RPMI/BSA and centrifuge at 100 x g for 3 min.
10. Repeat steps 3.8 and 3.9 once more, discard the cell pellet and lower 10 mL media.
11. Centrifuge the supernatents to pellet SECs, KCs, and HSCs at 200 x g for 10 min. at 4°C.
12. Prepare three 50 mL tubes containing 20 mL 25% Percoll in PBS on ice. Underlay with 15 mL 50% Percoll in each tube.
13. Resuspend the cell pellets in a total volume of 30 mL RPMI/BSA.
14. Carefully overlay each gradient with 10 mL of cells and centrifuge at 900 x g for 20 min at 4°C.
15. SECs and KCs have very close buoyant densities and are at the 25/50% interface. HSCs are typically at the 25%/media interface due to their higher buoyancy as lipid storing cells. Any remaining hepatocytes and blood cells have the lower buoyancies and are pelleted. Aspirate from the top down near the 25/50% interface and discard this material.
16. Collect the cells in the 25/50% interface and transfer to a fresh conical with cold RPMI. The final volume should be ~40 mL to dilute out the Percoll.
17. Centrifuge the conical at 350 x g for 10 min at 4°C to pellet the cells.
18. Resuspend the cells in ~10 mL pre-warmed RPMI containing 100 U/mL Penicillin/100 g/mL Streptomycin and place cells in an acid-washed glass Petri dish or crystallizing dish.
19. Incubate the cells for 15 min. at 37°C in a tissue culture incubator.
20. Rock or swirl the plate a little and then collect the SECs in the supernatant. The KCs adhere to the glass much more rapidly than SECs. Alternatively, SECs may be separated from KCs by immunopurification using anti-CD31 or anti-Stabilin2/HARE antibodies conjugated to magnetic beads.
21. Viability and cell numbers may be assessed by trypan blue exclusion using a hemacytometer or with using an automated cell counter.
22. Culture the SECs on fibronectin-coated plastic dishes at 37°C, 5% CO₂, RPMI/0.25% BSA with 40 ng/mL VEGF, 100 U/mL Penicillin, 100 μg/mL Streptomycin or with hepatocyte conditioned media.
23. Hepatocytes, KCs, and SECs may be assess for internalization of labeled material by the use of a gamma counter and normalizing to total cellular protein or by microscopy (if fluorescently labeled) using these culturing methods.

5. Representative results:

Hepatocyte purification is ≥97% and SEC purification is typically ≥95% using this method. Excision of the abdominal cavity, cannulation of the portal vein, and blanching of the liver all should occur within a minute for best results. HARE/Stabilin-2 is a specific receptor on liver SECs and is not expressed in other liver cell types. In this sample, cell lysates of both hepatocytes and SECs were separated by 5% SDS-PAGE and probed with a monoclonal antibody against both isoforms of Stabilin-2 (Fig. 3).

Unfractionated heparin injected into the blood stream is cleared by the liver¹⁶. Clearance is primarily performed by liver SECs in contrast to hepatocytes and KCs¹⁷. The Stabilin-2/HARE receptor is the main clearance receptor that binds and internalizes heparin in SECs¹⁸. In our example here, we labeled heparin with a biotin tag on the carboxylate group of GlcNAc/NS. The biotin was conjugated with iodinated streptavidin for detection of internalized heparin proteoglycan. Injection of the labeled heparin followed by exsanguination 30 minutes post-injection allows us to monitor which organs internalize this form of heparin. In this short time interval, the liver is the primary clearance organ (Fig. 4).

To more clearly understand which cell type is responsible for clearance, we added ¹²⁵I-SA-b-Hep to RPMI media supplemented with 0.05% BSA and allowed it to circulate through the liver for 20 min. Following collagenase digestion and cellular purification, the vast majority of labeled heparin is internalized by SECs in contrast to hepatocytes (Fig. 5).

Figure 1. Basic liver architecture. SECs form the walls of the sinusoids and are normally fenestrated (small clusters of circles). Stellate cells (HSCs) are found in the Space of Disse in contrast to Kupffer cells (KCs) which are normally present in the microvasculature of the sinusoids. Hepatocytes occupy the other side of the Space of Disse.

Figure 2. Schematic of the perfusion apparatus. A) Set-up of apparatus during the flushing/washing of the sinusoids of the liver. TBS is in a 1 L flask. B) A 125 mL flask containing ~60 mL Buffer 2 with collagenase is used for digestion of the liver in a closed circuit. The effluent line is also changed from the waste container to flask B through a notch cut in the rubber stopper. The oxygen line is not submerged into the buffer containing collagenase (flask B) to avoid foaming. The stoppers on each flask are notched to allow efficient transfer of the effluent line and to prevent increased pressure from the oxygen gas.

Figure 3. Hepatocyte preparations are not contaminated with SECs. Equal amounts of cell lysates from purified batches of hepatocytes (lane 1) and SECs (lane 2) were separated by 5% SDS-PAGE and blotted to nitrocellulose. Monoclonal antibody #30 which is specific against both isoforms (315 kDa and 190 kDa) of HARE/Stabilin-2 was used to probe the lysates.

Figure 4. Distribution of labeled heparin in organs. Rats were injected via the lateral tail vein with ¹²⁵I-SA-b-hep wait for 30 minutes and then exsanguinated. Blood was collected so as to not to give any organs artificially high readings. Counts per minute (CPM) of each organ were normalized against the weight of the organ in grams.

Figure 5. Amount of labeled heparin in hepatocytes and SECs. RPMI media containing ¹²⁵I-SA-b-Hep was allowed to circulate through an intact liver for 20 min followed by collagenase digestion and cellular purification. Equal amounts of hepatocyte and SEC cell protein lysates were quantified with the Bradford Assay and counted by a gamma counter.

Figure 6. Kupffer cells are separated from SECs by adhesion on glass. Cells were placed in an acid-washed glass crystallizing dish and allowed to adhere for 15 min at 37°C, 5% CO₂. The supernatent containing non-adhered cells was gently swirled and placed in a centrifuge tube. Lysates from both adhered cells on glass (lane 1) and from non-adhered cells (lane 2) were separated by 8% SDS-PAGE, blotted, and probed with an antibody against CD163 which is specific for Kupffer cells.

Figure 7. SECs plated on fibronectin coated plastic 6-well dishes were incubated overnight in RPMI supplemented with 0.1% BSA. Phase contrast images were taken at (A) 100x and (B) 200x magnification.